Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Meta-Analysis of Complete Remission Rates Following First-Line Salvage Treatment after Anti-CD19 CAR-T Failure in Adult Patients with Relapsed and Refractory B-Cell Acute Lymphoblastic Leukemia

Jaromir Tomasik, Dominik Bilicki, Grzegorz Basak

Blood (2024) 144 (Supplement 1): 1421.

https://doi.org/10.1182/blood-2024-204502

Published: 2024

Journal Articles

Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation for T-Cell Prolymphocytic Leukemia - a Study on Behalf of the Chronic Malignancies Working Party of the EBMT

Blood (2024) 144 (Supplement 1): 600.

https://doi.org/10.1182/blood-2024-198075

Published: 2024

Journal Articles

The Experience of Commercially Available CPX-351 Use As First-Line Treatment for Patients with Acute Myeloid Leukemia - a Report of Polish Adult Leukemia Group (PALG)

Blood (2024) 144 (Supplement 1): 4268.

https://doi.org/10.1182/blood-2024-203488

Published: 2024

Journal Articles

Artificial Intelligence-Based Algorithm for the Diagnosis of Idiopathic Multicentric Castleman's Disease in a Lower-Middle Income Country

Antonio Adolfo Guerra Soares Brandão, Danielle Leão Cordeiro De Farias, Michał Konopelko, Wojciech Amtmański, Mikolaj Mroz, Aleksandra Jurczuk, Maciej Majewski, Lukasz Szukalski, Grzegorz Basak, Bianca Milena Verboski, Caio Lopes de Assunção, Karol Lis, Michal Jerzy Dabrowski, Marek Dudziński

Blood (2024) 144 (Supplement 1): 7623.

https://doi.org/10.1182/blood-2024-198242

Published: 2024

Journal Articles

Central Nervous System Disorders (CNSD) Following Hematopoietic Stem Cell Transplantation (HSCT): A Prospective Study from the Infectious Diseases Working Party (IDWP) and the Transplant Complications Working Party (TCWP), European Society of Blood and Marrow Transplantation (EBMT)

Blood (2024) 144 (Supplement 1): 3497.

https://doi.org/10.1182/blood-2024-194695

Published: 2024

Journal Articles

Higher Prevalence of Chronic Kidney Disease in Myelodysplastic Syndromes Patients Compared to Age- Adjusted General Population - Results from the Polish Adult Leukemia Group (PALG) Registry

Blood (2023) 142 (Supplement 1): 3230.

https://doi.org/10.1182/blood-2023-179827

Published: 2023

Journal Articles

Early Mortality in Patients with Multiple Myeloma Treated with Novel Agents - Analysis from Polish Myeloma Study Group

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-143003

Published: 2020

Journal Articles

Transplantation Outcome By Disease Risk and Donor Type over Time: An Analysis of 100,000 Allogeneic Stem Cell Transplantation on Behalf of the Acute Leukemia Working Party of the EBMT

Roni Shouval, Joshua Fein, Myriam Labopin, MD, Nicolaus Kröger, Rafael F Duarte, MD PhD FRCP, Peter Bader, MD PhD, Bonini Chiara, MD, Jurgen Kuball, MD, Grzegorz Basak, MD PhD, Carlo Dufour, MD, Arjan Lankester, MD PhD, Silvia Montoto, John A Snowden, MD, Jan Styczynski, PhD, Mohamad Mohty, MD PhD, Arnon Nagler, MD

Blood (2017) 130 (Supplement 1): 668.

https://doi.org/10.1182/blood.V130.Suppl_1.668.668

Published: 2017

Journal Articles

Donor EBV-Positive Serostatus Increases the Risk of Chronic GVHD in Patients with Myeloid and Lymphoid Malignancies Other Than Acute Leukemia: Infectious Diseases Working Party EBMT Study

Blood (2017) 130 (Supplement 1): 4488.

https://doi.org/10.1182/blood.V130.Suppl_1.4488.4488

Published: 2017

Journal Articles

Use of Busulfan in Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Adults: A Survey By the Complications and Quality of Life Working Party of the EBMT

Tapani Ruutu, MD PhD, Steffie van der Werf, Anja van Biezen, Janne Backman, MD PhD, Arnon Nagler, MD, Silvia Montoto, Mohamad Mohty, MD PhD, Dietger Niederwieser, MD, Claudia Langebrake, PD, Zinaida Peric, MD PhD, Rafael F Duarte, MD PhD FRCP, Grzegorz Basak, MD PhD

Blood (2017) 130 (Supplement 1): 1955.

https://doi.org/10.1182/blood.V130.Suppl_1.1955.1955

Published: 2017

Journal Articles

The Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: An Analysis By the EBMT Complications and Quality of Life WP

Blood (2017) 130 (Supplement 1): 3324.

https://doi.org/10.1182/blood.V130.Suppl_1.3324.3324

Published: 2017

Journal Articles

Outcome of Patients with Second Cancer after Hematopoietic Stem Cell Transplantation: On Behalf of the Complications and Quality of Life Working Party of the EBMT

André Tichelli, MD, Eric Beohou, Myriam Labopin, Gérard Socié, MD PhD, Alicia Rovó, MD, Manuela Badoglio, Anja van Biezen, Grzegorz Basak, MD, Rafael F. Duarte, MD PhD, Nina Salooja, DM, FRCP, FRCPath

Blood (2016) 128 (22): 3441.

https://doi.org/10.1182/blood.V128.22.3441.3441

Published: 2016

Journal Articles

Conditioning Intensity Does Not Influence the Outcome of Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome. a Joint Study By the Polish Adult Leukemia Group and the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation

Blood (2014) 124 (21): 2564.

https://doi.org/10.1182/blood.V124.21.2564.2564

Published: 2014

Journal Articles

Src Family Tyrosine Kinases Are Involved in the Transcriptional Regulation of CD20 Levels

Magdalena Winiarska, PhD, Jacek Bil, MD, PhD, Kamil Bojarczuk, BSc, Dominika Nowis, MD, PhD, Malgorzata Wanczyk, MSc, Michal Dwojak, Grzegorz Basak, MD, PhD, Tomasz Stoklosa, MD, PhD, Jakub Golab, MD, PhD

Blood (2011) 118 (21): 1661.

https://doi.org/10.1182/blood.V118.21.1661.1661

Published: 2011

Journal Articles

Stem Cell Mobilization in Poor Mobilizers Using Plerixafor and G-CSF with or without Chemotherapy: A European Perspective

Maximilian M Fresen, MD, Rafael F. Duarte, MD, PhD, Jane F Apperley, MBChB, MD, FRCP, FRCPath, Grzegorz Basak, MD, PhD, Kenneth W Douglas, MD, Ian H Gabriel, MD, Catarina Geraldes, MD, Ozren Jaksic, MD, PhD, Zdenek Koristek, MD, PhD, Nicolaus Kröger, Francesco Lanza, MD, Roberto M. Lemoli, MD, Gabor Mikala, MD, PhD, Dominik Selleslag, MD, Nina Worel, MD, Florian Lange, Mohamad Mohty, Kai Hübel, MD

Blood (2011) 118 (21): 2993.

https://doi.org/10.1182/blood.V118.21.2993.2993

Published: 2011

Journal Articles

Statins Increase Antileukemic Potency of Imatinib Through the Inhibition of MDR/ABCB1 and BCRP/ABCG2 Drug Transporters Activity

Eliza Glodkowska-Mrowka, MD, Piotr Mrowka, M.Sc., Magdalena Winiarska, PhD, Grzegorz Basak, MD, PhD, Joanna Niesiobedzka-Krezel, MD, Ilona Seferynska, MD, PhD, Pawel Krzysztof Wlodarski, MD, PhD, Marek Jakobisiak, MD, PhD, Tomasz Stoklosa, MD, PhD

Blood (2011) 118 (21): 2742.

https://doi.org/10.1182/blood.V118.21.2742.2742

Published: 2011

Journal Articles

Sorafenib Affects Membrane Complement Inhibitors and Improves Antitumor Activity of Rituximab,

Jakub Golab, MD, PhD, Jacek Bil, MD, PhD, Kamil Bojarczuk, BSc, Dominika Nowis, MD, PhD, Marcin Okroj, Ph.D., Grzegorz Basak, MD, PhD, Tomasz Stoklosa, MD, PhD, Magdalena Winiarska, PhD

Blood (2011) 118 (21): 3723.

https://doi.org/10.1182/blood.V118.21.3723.3723

Published: 2011

Journal Articles

Plerixafor for Autologous Peripheral Blood Stem Cell Mobilization in Patients Previously Treated with Fludarabine or Lenalidomide

Florent Malard, Nicolaus Kröger, Ian H Gabriel, Dr, Kai Hübel, MD, Jane F. Apperley, MBChB, FRCP, FRCPath, Grzegorz Basak, MD, PhD, Kenneth W Douglas, MD, Catarina Geraldes, MD, Ozren Jaksic, MD, PhD, Zdenek Koristek, MD, PhD, Francesco Lanza, MD, Roberto M. Lemoli, MD, Gabor Mikala, MD, PhD, Dominik Selleslag, MD, Nina Worel, MD, Rafael F. Duarte, MD, PhD, Mohamad Mohty

Blood (2011) 118 (21): 1932.

https://doi.org/10.1182/blood.V118.21.1932.1932

Published: 2011

Journal Articles

Potentiation of the Antileukemic Effects of Imatinib through the Modulation of BCRP/ABCG2 Activity.

Eliza Glodkowska-Mrowka, MD, Magda Winiarska, PhD, Piotr Mrowka, M.Sc., Grzegorz Basak, MD, PhD, Joanna Niesiobedzka-Krezel, MD, Ilona Seferynska, MD, PhD, Tomasz Stoklosa, MD, PhD

Blood (2010) 116 (21): 3400.

https://doi.org/10.1182/blood.V116.21.3400.3400

Published: 2010

Journal Articles

BCR/ABL Kinase Inhibits Mismatch Repair To Reduce Apoptosis and Induce Point Mutations.

Tomasz Stoklosa, MD, PhD, Tomasz Poplawski, PhD, Grzegorz Basak, MD, PhD, Artur Slupianek, PhD, Janusz Blasiak, PhD, Ilona Seferynska, MD, PhD, Tomasz Skorski, MD, PhD

Blood (2007) 110 (11): 32.

https://doi.org/10.1182/blood.V110.11.32.32

Published: 2007

NARROW

Meta-Analysis of Complete Remission Rates Following First-Line Salvage Treatment after Anti-CD19 CAR-T Failure in Adult Patients with Relapsed and Refractory B-Cell Acute Lymphoblastic Leukemia

Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation for T-Cell Prolymphocytic Leukemia - a Study on Behalf of the Chronic Malignancies Working Party of the EBMT

The Experience of Commercially Available CPX-351 Use As First-Line Treatment for Patients with Acute Myeloid Leukemia - a Report of Polish Adult Leukemia Group (PALG)

Artificial Intelligence-Based Algorithm for the Diagnosis of Idiopathic Multicentric Castleman's Disease in a Lower-Middle Income Country

Central Nervous System Disorders (CNSD) Following Hematopoietic Stem Cell Transplantation (HSCT): A Prospective Study from the Infectious Diseases Working Party (IDWP) and the Transplant Complications Working Party (TCWP), European Society of Blood and Marrow Transplantation (EBMT)

Higher Prevalence of Chronic Kidney Disease in Myelodysplastic Syndromes Patients Compared to Age- Adjusted General Population - Results from the Polish Adult Leukemia Group (PALG) Registry

Early Mortality in Patients with Multiple Myeloma Treated with Novel Agents - Analysis from Polish Myeloma Study Group

Transplantation Outcome By Disease Risk and Donor Type over Time: An Analysis of 100,000 Allogeneic Stem Cell Transplantation on Behalf of the Acute Leukemia Working Party of the EBMT

Donor EBV-Positive Serostatus Increases the Risk of Chronic GVHD in Patients with Myeloid and Lymphoid Malignancies Other Than Acute Leukemia: Infectious Diseases Working Party EBMT Study

Use of Busulfan in Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Adults: A Survey By the Complications and Quality of Life Working Party of the EBMT

The Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: An Analysis By the EBMT Complications and Quality of Life WP

Outcome of Patients with Second Cancer after Hematopoietic Stem Cell Transplantation: On Behalf of the Complications and Quality of Life Working Party of the EBMT

Conditioning Intensity Does Not Influence the Outcome of Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome. a Joint Study By the Polish Adult Leukemia Group and the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation

Src Family Tyrosine Kinases Are Involved in the Transcriptional Regulation of CD20 Levels

Stem Cell Mobilization in Poor Mobilizers Using Plerixafor and G-CSF with or without Chemotherapy: A European Perspective

Statins Increase Antileukemic Potency of Imatinib Through the Inhibition of MDR/ABCB1 and BCRP/ABCG2 Drug Transporters Activity

Sorafenib Affects Membrane Complement Inhibitors and Improves Antitumor Activity of Rituximab,

Plerixafor for Autologous Peripheral Blood Stem Cell Mobilization in Patients Previously Treated with Fludarabine or Lenalidomide

Potentiation of the Antileukemic Effects of Imatinib through the Modulation of BCRP/ABCG2 Activity.

BCR/ABL Kinase Inhibits Mismatch Repair To Reduce Apoptosis and Induce Point Mutations.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only